nodes	percent_of_prediction	percent_of_DWPC	metapath
Etidronic acid—PTPRS—bone marrow—hematologic cancer	0.018	0.133	CbGeAlD
Etidronic acid—PTPRS—lung—hematologic cancer	0.0163	0.121	CbGeAlD
Etidronic acid—ATP6V1A—hematopoietic system—hematologic cancer	0.0162	0.12	CbGeAlD
Etidronic acid—PTPRS—testis—hematologic cancer	0.0154	0.114	CbGeAlD
Etidronic acid—ATP6V1A—gonad—hematologic cancer	0.0123	0.0911	CbGeAlD
Etidronic acid—PTPRS—lymph node—hematologic cancer	0.0111	0.0825	CbGeAlD
Etidronic acid—ATP6V1A—blood—hematologic cancer	0.0107	0.0794	CbGeAlD
Etidronic acid—ATP6V1A—bone marrow—hematologic cancer	0.0104	0.0768	CbGeAlD
Etidronic acid—ATP6V1A—lung—hematologic cancer	0.0094	0.0696	CbGeAlD
Etidronic acid—ATP6V1A—testis—hematologic cancer	0.00887	0.0656	CbGeAlD
Etidronic acid—ATP6V1A—lymph node—hematologic cancer	0.00643	0.0476	CbGeAlD
Etidronic acid—ATP6V1A—Transmembrane transport of small molecules—TUBB2A—hematologic cancer	0.000832	0.00429	CbGpPWpGaD
Etidronic acid—ATP6V1A—Signaling by Insulin receptor—JAK2—hematologic cancer	0.000811	0.00418	CbGpPWpGaD
Etidronic acid—ATP6V1A—Disease—B3GAT1—hematologic cancer	0.000786	0.00405	CbGpPWpGaD
Etidronic acid—ATP6V1A—Disease—CHMP5—hematologic cancer	0.000786	0.00405	CbGpPWpGaD
Etidronic acid—ATP6V1A—Signaling Pathways—RHOJ—hematologic cancer	0.000773	0.00398	CbGpPWpGaD
Etidronic acid—ATP6V1A—Signaling by Insulin receptor—PIK3CB—hematologic cancer	0.00077	0.00397	CbGpPWpGaD
Etidronic acid—ATP6V1A—Signaling by Insulin receptor—MTOR—hematologic cancer	0.00077	0.00397	CbGpPWpGaD
Etidronic acid—PTPRS—Extracellular matrix organization—CASP3—hematologic cancer	0.000751	0.00387	CbGpPWpGaD
Etidronic acid—ATP6V1A—Transmembrane transport of small molecules—ABCC3—hematologic cancer	0.00073	0.00376	CbGpPWpGaD
Etidronic acid—ATP6V1A—Disease—HDAC11—hematologic cancer	0.000711	0.00366	CbGpPWpGaD
Etidronic acid—ATP6V1A—Signaling Pathways—IFT172—hematologic cancer	0.000689	0.00355	CbGpPWpGaD
Etidronic acid—ATP6V1A—Disease—BCR—hematologic cancer	0.000682	0.00351	CbGpPWpGaD
Etidronic acid—ATP6V1A—Disease—LIG4—hematologic cancer	0.000682	0.00351	CbGpPWpGaD
Etidronic acid—ATP6V1A—Transmembrane transport of small molecules—SLC22A1—hematologic cancer	0.000668	0.00344	CbGpPWpGaD
Etidronic acid—ATP6V1A—Disease—PC—hematologic cancer	0.000656	0.00338	CbGpPWpGaD
Etidronic acid—ATP6V1A—Disease—PSIP1—hematologic cancer	0.000656	0.00338	CbGpPWpGaD
Etidronic acid—ATP6V1A—Disease—SLC35B2—hematologic cancer	0.000634	0.00327	CbGpPWpGaD
Etidronic acid—ATP6V1A—Disease—HDAC10—hematologic cancer	0.000634	0.00327	CbGpPWpGaD
Etidronic acid—ATP6V1A—Transmembrane transport of small molecules—NUP98—hematologic cancer	0.00063	0.00325	CbGpPWpGaD
Etidronic acid—ATP6V1A—Signaling Pathways—PPEF1—hematologic cancer	0.00063	0.00325	CbGpPWpGaD
Etidronic acid—ATP6V1A—Transmembrane transport of small molecules—ADCY7—hematologic cancer	0.000612	0.00315	CbGpPWpGaD
Etidronic acid—ATP6V1A—Transmembrane transport of small molecules—NUP214—hematologic cancer	0.000608	0.00313	CbGpPWpGaD
Etidronic acid—ATP6V1A—Transmembrane transport of small molecules—ABCG2—hematologic cancer	0.000595	0.00307	CbGpPWpGaD
Etidronic acid—ATP6V1A—Signaling by Insulin receptor—NRAS—hematologic cancer	0.000594	0.00306	CbGpPWpGaD
Etidronic acid—PTPRS—Extracellular matrix organization—TGFB1—hematologic cancer	0.000585	0.00302	CbGpPWpGaD
Etidronic acid—ATP6V1A—Signaling by Insulin receptor—MAPK3—hematologic cancer	0.000569	0.00293	CbGpPWpGaD
Etidronic acid—ATP6V1A—Transmembrane transport of small molecules—TFRC—hematologic cancer	0.000531	0.00273	CbGpPWpGaD
Etidronic acid—ATP6V1A—Signaling by Insulin receptor—KRAS—hematologic cancer	0.000511	0.00263	CbGpPWpGaD
Etidronic acid—ATP6V1A—Disease—AGRN—hematologic cancer	0.000507	0.00261	CbGpPWpGaD
Etidronic acid—ATP6V1A—Disease—SNCA—hematologic cancer	0.000507	0.00261	CbGpPWpGaD
Etidronic acid—ATP6V1A—Disease—RPLP1—hematologic cancer	0.000507	0.00261	CbGpPWpGaD
Etidronic acid—ATP6V1A—Signaling Pathways—HDAC11—hematologic cancer	0.000498	0.00257	CbGpPWpGaD
Etidronic acid—ATP6V1A—Disease—LEF1—hematologic cancer	0.000489	0.00252	CbGpPWpGaD
Etidronic acid—ATP6V1A—Disease—HMMR—hematologic cancer	0.00048	0.00248	CbGpPWpGaD
Etidronic acid—ATP6V1A—Signaling Pathways—BCR—hematologic cancer	0.000477	0.00246	CbGpPWpGaD
Etidronic acid—ATP6V1A—Signaling by Insulin receptor—PIK3CA—hematologic cancer	0.00047	0.00242	CbGpPWpGaD
Etidronic acid—ATP6V1A—Disease—ELL—hematologic cancer	0.000452	0.00233	CbGpPWpGaD
Etidronic acid—ATP6V1A—Transmembrane transport of small molecules—CYCS—hematologic cancer	0.000445	0.00229	CbGpPWpGaD
Etidronic acid—ATP6V1A—Signaling Pathways—HDAC10—hematologic cancer	0.000444	0.00229	CbGpPWpGaD
Etidronic acid—ATP6V1A—Disease—ACP5—hematologic cancer	0.000439	0.00226	CbGpPWpGaD
Etidronic acid—ATP6V1A—Signaling by Insulin receptor—HRAS—hematologic cancer	0.000434	0.00224	CbGpPWpGaD
Etidronic acid—ATP6V1A—Disease—NCOR2—hematologic cancer	0.000434	0.00223	CbGpPWpGaD
Etidronic acid—ATP6V1A—Signaling by Insulin receptor—IL6—hematologic cancer	0.000416	0.00214	CbGpPWpGaD
Etidronic acid—ATP6V1A—Disease—IDH1—hematologic cancer	0.000413	0.00213	CbGpPWpGaD
Etidronic acid—ATP6V1A—Disease—GSTO1—hematologic cancer	0.000408	0.0021	CbGpPWpGaD
Etidronic acid—ATP6V1A—Signaling Pathways—ARHGEF12—hematologic cancer	0.000406	0.00209	CbGpPWpGaD
Etidronic acid—ATP6V1A—Disease—AGO2—hematologic cancer	0.0004	0.00206	CbGpPWpGaD
Etidronic acid—ATP6V1A—Signaling Pathways—ARHGEF1—hematologic cancer	0.000396	0.00204	CbGpPWpGaD
Etidronic acid—ATP6V1A—Disease—HDAC9—hematologic cancer	0.000396	0.00204	CbGpPWpGaD
Etidronic acid—ATP6V1A—Disease—H3F3B—hematologic cancer	0.000392	0.00202	CbGpPWpGaD
Etidronic acid—ATP6V1A—Disease—NPM1—hematologic cancer	0.000377	0.00194	CbGpPWpGaD
Etidronic acid—ATP6V1A—Transmembrane transport of small molecules—ABCB1—hematologic cancer	0.000372	0.00191	CbGpPWpGaD
Etidronic acid—ATP6V1A—Disease—FGF19—hematologic cancer	0.000361	0.00186	CbGpPWpGaD
Etidronic acid—ATP6V1A—Disease—RPS14—hematologic cancer	0.000358	0.00185	CbGpPWpGaD
Etidronic acid—ATP6V1A—Disease—DKK1—hematologic cancer	0.000355	0.00183	CbGpPWpGaD
Etidronic acid—ATP6V1A—Signaling Pathways—AGRN—hematologic cancer	0.000355	0.00183	CbGpPWpGaD
Etidronic acid—ATP6V1A—Signaling Pathways—CCL17—hematologic cancer	0.000355	0.00183	CbGpPWpGaD
Etidronic acid—ATP6V1A—Disease—STAT5B—hematologic cancer	0.000353	0.00182	CbGpPWpGaD
Etidronic acid—ATP6V1A—Disease—NUP98—hematologic cancer	0.000353	0.00182	CbGpPWpGaD
Etidronic acid—ATP6V1A—Signaling Pathways—CXCR5—hematologic cancer	0.000348	0.00179	CbGpPWpGaD
Etidronic acid—ATP6V1A—Disease—CST3—hematologic cancer	0.000345	0.00178	CbGpPWpGaD
Etidronic acid—ATP6V1A—Disease—ADCY7—hematologic cancer	0.000342	0.00176	CbGpPWpGaD
Etidronic acid—ATP6V1A—Signaling Pathways—LEF1—hematologic cancer	0.000342	0.00176	CbGpPWpGaD
Etidronic acid—ATP6V1A—Disease—NUP214—hematologic cancer	0.00034	0.00175	CbGpPWpGaD
Etidronic acid—ATP6V1A—Signaling Pathways—GNA13—hematologic cancer	0.000336	0.00173	CbGpPWpGaD
Etidronic acid—ATP6V1A—Disease—XIAP—hematologic cancer	0.000333	0.00172	CbGpPWpGaD
Etidronic acid—ATP6V1A—Disease—MTR—hematologic cancer	0.000333	0.00172	CbGpPWpGaD
Etidronic acid—ATP6V1A—Signaling Pathways—TIAM1—hematologic cancer	0.000331	0.00171	CbGpPWpGaD
Etidronic acid—ATP6V1A—Disease—ENO2—hematologic cancer	0.000327	0.00168	CbGpPWpGaD
Etidronic acid—ATP6V1A—Disease—SMARCA4—hematologic cancer	0.000324	0.00167	CbGpPWpGaD
Etidronic acid—ATP6V1A—Signaling Pathways—JAK3—hematologic cancer	0.000321	0.00165	CbGpPWpGaD
Etidronic acid—ATP6V1A—Disease—SDC1—hematologic cancer	0.00031	0.00159	CbGpPWpGaD
Etidronic acid—ATP6V1A—Signaling Pathways—CCR7—hematologic cancer	0.000308	0.00159	CbGpPWpGaD
Etidronic acid—ATP6V1A—Signaling Pathways—CXCL13—hematologic cancer	0.000308	0.00159	CbGpPWpGaD
Etidronic acid—ATP6V1A—Signaling Pathways—NCOR2—hematologic cancer	0.000304	0.00156	CbGpPWpGaD
Etidronic acid—ATP6V1A—Signaling Pathways—IL3RA—hematologic cancer	0.0003	0.00154	CbGpPWpGaD
Etidronic acid—ATP6V1A—Signaling Pathways—CRKL—hematologic cancer	0.0003	0.00154	CbGpPWpGaD
Etidronic acid—ATP6V1A—Disease—LCK—hematologic cancer	0.0003	0.00154	CbGpPWpGaD
Etidronic acid—ATP6V1A—Disease—H3F3A—hematologic cancer	0.000294	0.00151	CbGpPWpGaD
Etidronic acid—ATP6V1A—Signaling Pathways—RGS2—hematologic cancer	0.000289	0.00149	CbGpPWpGaD
Etidronic acid—ATP6V1A—Signaling Pathways—TRH—hematologic cancer	0.000286	0.00147	CbGpPWpGaD
Etidronic acid—ATP6V1A—Signaling Pathways—TRIO—hematologic cancer	0.000286	0.00147	CbGpPWpGaD
Etidronic acid—ATP6V1A—Signaling Pathways—CMA1—hematologic cancer	0.000286	0.00147	CbGpPWpGaD
Etidronic acid—ATP6V1A—Disease—PRKCZ—hematologic cancer	0.000286	0.00147	CbGpPWpGaD
Etidronic acid—ATP6V1A—Disease—CALR—hematologic cancer	0.000281	0.00145	CbGpPWpGaD
Etidronic acid—ATP6V1A—Signaling Pathways—AGO2—hematologic cancer	0.00028	0.00144	CbGpPWpGaD
Etidronic acid—ATP6V1A—Signaling Pathways—SPHK1—hematologic cancer	0.00028	0.00144	CbGpPWpGaD
Etidronic acid—ATP6V1A—Signaling Pathways—HDAC9—hematologic cancer	0.000277	0.00143	CbGpPWpGaD
Etidronic acid—ATP6V1A—Signaling Pathways—LPAR1—hematologic cancer	0.000277	0.00143	CbGpPWpGaD
Etidronic acid—ATP6V1A—Disease—PARP1—hematologic cancer	0.000276	0.00142	CbGpPWpGaD
Etidronic acid—ATP6V1A—Signaling Pathways—H3F3B—hematologic cancer	0.000274	0.00141	CbGpPWpGaD
Etidronic acid—ATP6V1A—Disease—FBXW7—hematologic cancer	0.000271	0.0014	CbGpPWpGaD
Etidronic acid—ATP6V1A—Disease—HDAC2—hematologic cancer	0.000266	0.00137	CbGpPWpGaD
Etidronic acid—ATP6V1A—Disease—CXCR4—hematologic cancer	0.000266	0.00137	CbGpPWpGaD
Etidronic acid—ATP6V1A—Disease—CD44—hematologic cancer	0.000263	0.00136	CbGpPWpGaD
Etidronic acid—ATP6V1A—Disease—CBL—hematologic cancer	0.000259	0.00134	CbGpPWpGaD
Etidronic acid—ATP6V1A—Signaling Pathways—PDE4B—hematologic cancer	0.000255	0.00131	CbGpPWpGaD
Etidronic acid—ATP6V1A—Signaling Pathways—CNR2—hematologic cancer	0.000255	0.00131	CbGpPWpGaD
Etidronic acid—ATP6V1A—Signaling Pathways—FGF19—hematologic cancer	0.000253	0.0013	CbGpPWpGaD
Etidronic acid—ATP6V1A—Signaling Pathways—RAC2—hematologic cancer	0.000251	0.00129	CbGpPWpGaD
Etidronic acid—ATP6V1A—Signaling Pathways—DKK1—hematologic cancer	0.000249	0.00128	CbGpPWpGaD
Etidronic acid—ATP6V1A—Transmembrane transport of small molecules—CREBBP—hematologic cancer	0.000248	0.00128	CbGpPWpGaD
Etidronic acid—ATP6V1A—Disease—HSP90AA1—hematologic cancer	0.000247	0.00128	CbGpPWpGaD
Etidronic acid—ATP6V1A—Signaling Pathways—STAT5B—hematologic cancer	0.000247	0.00127	CbGpPWpGaD
Etidronic acid—ATP6V1A—Signaling Pathways—ADCY7—hematologic cancer	0.00024	0.00123	CbGpPWpGaD
Etidronic acid—ATP6V1A—Disease—STAT1—hematologic cancer	0.000239	0.00123	CbGpPWpGaD
Etidronic acid—ATP6V1A—Signaling Pathways—XIAP—hematologic cancer	0.000233	0.0012	CbGpPWpGaD
Etidronic acid—ATP6V1A—Transmembrane transport of small molecules—ALB—hematologic cancer	0.000232	0.0012	CbGpPWpGaD
Etidronic acid—Angioedema—Dexamethasone—hematologic cancer	0.000231	0.000345	CcSEcCtD
Etidronic acid—Angioedema—Betamethasone—hematologic cancer	0.000231	0.000345	CcSEcCtD
Etidronic acid—Diarrhoea—Thalidomide—hematologic cancer	0.000231	0.000345	CcSEcCtD
Etidronic acid—Rash—Vinorelbine—hematologic cancer	0.000231	0.000344	CcSEcCtD
Etidronic acid—Dermatitis—Vinorelbine—hematologic cancer	0.000231	0.000344	CcSEcCtD
Etidronic acid—Headache—Vinorelbine—hematologic cancer	0.000229	0.000342	CcSEcCtD
Etidronic acid—Asthma—Doxorubicin—hematologic cancer	0.000229	0.000341	CcSEcCtD
Etidronic acid—Hypersensitivity—Vincristine—hematologic cancer	0.000228	0.00034	CcSEcCtD
Etidronic acid—Pruritus—Alitretinoin—hematologic cancer	0.000228	0.000339	CcSEcCtD
Etidronic acid—ATP6V1A—Signaling Pathways—SMARCA4—hematologic cancer	0.000227	0.00117	CbGpPWpGaD
Etidronic acid—ATP6V1A—Signaling Pathways—SH2B3—hematologic cancer	0.000227	0.00117	CbGpPWpGaD
Etidronic acid—Infection—Triamcinolone—hematologic cancer	0.000226	0.000337	CcSEcCtD
Etidronic acid—Feeling abnormal—Cisplatin—hematologic cancer	0.000226	0.000337	CcSEcCtD
Etidronic acid—ATP6V1A—Signaling Pathways—GZMB—hematologic cancer	0.000226	0.00116	CbGpPWpGaD
Etidronic acid—Paraesthesia—Etoposide—hematologic cancer	0.000225	0.000336	CcSEcCtD
Etidronic acid—Pruritus—Ifosfamide—hematologic cancer	0.000225	0.000335	CcSEcCtD
Etidronic acid—Alopecia—Prednisone—hematologic cancer	0.000224	0.000334	CcSEcCtD
Etidronic acid—ATP6V1A—Disease—GRB2—hematologic cancer	0.000223	0.00115	CbGpPWpGaD
Etidronic acid—ATP6V1A—Disease—PDGFA—hematologic cancer	0.000223	0.00115	CbGpPWpGaD
Etidronic acid—Nausea—Bortezomib—hematologic cancer	0.000223	0.000332	CcSEcCtD
Etidronic acid—Hypersensitivity—Irinotecan—hematologic cancer	0.000222	0.000331	CcSEcCtD
Etidronic acid—Hypersensitivity—Mitoxantrone—hematologic cancer	0.000222	0.000331	CcSEcCtD
Etidronic acid—Paraesthesia—Prednisolone—hematologic cancer	0.000222	0.000331	CcSEcCtD
Etidronic acid—Vomiting—Thiotepa—hematologic cancer	0.000222	0.000331	CcSEcCtD
Etidronic acid—Diarrhoea—Carmustine—hematologic cancer	0.000222	0.000331	CcSEcCtD
Etidronic acid—Nausea—Bleomycin—hematologic cancer	0.000221	0.000329	CcSEcCtD
Etidronic acid—ATP6V1A—Signaling Pathways—CTNNA1—hematologic cancer	0.00022	0.00114	CbGpPWpGaD
Etidronic acid—Erythema—Prednisone—hematologic cancer	0.00022	0.000329	CcSEcCtD
Etidronic acid—Rash—Thiotepa—hematologic cancer	0.00022	0.000329	CcSEcCtD
Etidronic acid—Dermatitis—Thiotepa—hematologic cancer	0.00022	0.000328	CcSEcCtD
Etidronic acid—Diarrhoea—Alitretinoin—hematologic cancer	0.00022	0.000328	CcSEcCtD
Etidronic acid—Agranulocytosis—Methotrexate—hematologic cancer	0.00022	0.000328	CcSEcCtD
Etidronic acid—ATP6V1A—Disease—KITLG—hematologic cancer	0.00022	0.00113	CbGpPWpGaD
Etidronic acid—ATP6V1A—Signaling Pathways—CCL3—hematologic cancer	0.000219	0.00113	CbGpPWpGaD
Etidronic acid—ATP6V1A—Signaling Pathways—HSPB1—hematologic cancer	0.000219	0.00113	CbGpPWpGaD
Etidronic acid—ATP6V1A—Signaling Pathways—EIF4EBP1—hematologic cancer	0.000219	0.00113	CbGpPWpGaD
Etidronic acid—Headache—Thiotepa—hematologic cancer	0.000219	0.000326	CcSEcCtD
Etidronic acid—Stevens-Johnson syndrome—Epirubicin—hematologic cancer	0.000219	0.000326	CcSEcCtD
Etidronic acid—Diarrhoea—Ifosfamide—hematologic cancer	0.000217	0.000324	CcSEcCtD
Etidronic acid—Pancytopenia—Doxorubicin—hematologic cancer	0.000217	0.000324	CcSEcCtD
Etidronic acid—Nausea—Vinorelbine—hematologic cancer	0.000217	0.000324	CcSEcCtD
Etidronic acid—ATP6V1A—Signaling Pathways—PTHLH—hematologic cancer	0.000217	0.00112	CbGpPWpGaD
Etidronic acid—ATP6V1A—Signaling Pathways—SDC1—hematologic cancer	0.000217	0.00112	CbGpPWpGaD
Etidronic acid—Neuropathy peripheral—Epirubicin—hematologic cancer	0.000216	0.000322	CcSEcCtD
Etidronic acid—Vomiting—Thalidomide—hematologic cancer	0.000215	0.00032	CcSEcCtD
Etidronic acid—Constipation—Etoposide—hematologic cancer	0.000215	0.00032	CcSEcCtD
Etidronic acid—ATP6V1A—Disease—STAT5A—hematologic cancer	0.000215	0.00111	CbGpPWpGaD
Etidronic acid—Rash—Thalidomide—hematologic cancer	0.000213	0.000318	CcSEcCtD
Etidronic acid—Discomfort—Betamethasone—hematologic cancer	0.000213	0.000317	CcSEcCtD
Etidronic acid—Discomfort—Dexamethasone—hematologic cancer	0.000213	0.000317	CcSEcCtD
Etidronic acid—Dermatitis—Thalidomide—hematologic cancer	0.000213	0.000317	CcSEcCtD
Etidronic acid—ATP6V1A—Disease—CDKN2B—hematologic cancer	0.000213	0.0011	CbGpPWpGaD
Etidronic acid—Diarrhoea—Vincristine—hematologic cancer	0.000212	0.000316	CcSEcCtD
Etidronic acid—Headache—Thalidomide—hematologic cancer	0.000212	0.000316	CcSEcCtD
Etidronic acid—ATP6V1A—Signaling Pathways—PTGER4—hematologic cancer	0.000211	0.00109	CbGpPWpGaD
Etidronic acid—ATP6V1A—Signaling Pathways—LCK—hematologic cancer	0.00021	0.00108	CbGpPWpGaD
Etidronic acid—Pruritus—Gemcitabine—hematologic cancer	0.000208	0.00031	CcSEcCtD
Etidronic acid—Nausea—Thiotepa—hematologic cancer	0.000208	0.000309	CcSEcCtD
Etidronic acid—Musculoskeletal discomfort—Triamcinolone—hematologic cancer	0.000207	0.000309	CcSEcCtD
Etidronic acid—Feeling abnormal—Etoposide—hematologic cancer	0.000207	0.000308	CcSEcCtD
Etidronic acid—Diarrhoea—Irinotecan—hematologic cancer	0.000207	0.000308	CcSEcCtD
Etidronic acid—Diarrhoea—Mitoxantrone—hematologic cancer	0.000207	0.000308	CcSEcCtD
Etidronic acid—Vomiting—Carmustine—hematologic cancer	0.000206	0.000308	CcSEcCtD
Etidronic acid—Agranulocytosis—Epirubicin—hematologic cancer	0.000206	0.000307	CcSEcCtD
Etidronic acid—ATP6V1A—Signaling Pathways—H3F3A—hematologic cancer	0.000206	0.00106	CbGpPWpGaD
Etidronic acid—ATP6V1A—Disease—CD86—hematologic cancer	0.000206	0.00106	CbGpPWpGaD
Etidronic acid—Gastrointestinal pain—Etoposide—hematologic cancer	0.000205	0.000306	CcSEcCtD
Etidronic acid—Infection—Dexamethasone—hematologic cancer	0.000205	0.000306	CcSEcCtD
Etidronic acid—Infection—Betamethasone—hematologic cancer	0.000205	0.000306	CcSEcCtD
Etidronic acid—Rash—Carmustine—hematologic cancer	0.000205	0.000305	CcSEcCtD
Etidronic acid—Dermatitis—Carmustine—hematologic cancer	0.000205	0.000305	CcSEcCtD
Etidronic acid—Vomiting—Alitretinoin—hematologic cancer	0.000204	0.000305	CcSEcCtD
Etidronic acid—Paraesthesia—Triamcinolone—hematologic cancer	0.000204	0.000305	CcSEcCtD
Etidronic acid—Feeling abnormal—Prednisolone—hematologic cancer	0.000204	0.000304	CcSEcCtD
Etidronic acid—Anaemia—Prednisone—hematologic cancer	0.000204	0.000304	CcSEcCtD
Etidronic acid—Headache—Carmustine—hematologic cancer	0.000203	0.000303	CcSEcCtD
Etidronic acid—ATP6V1A—Disease—HES1—hematologic cancer	0.000203	0.00105	CbGpPWpGaD
Etidronic acid—Rash—Alitretinoin—hematologic cancer	0.000203	0.000302	CcSEcCtD
Etidronic acid—Dermatitis—Alitretinoin—hematologic cancer	0.000203	0.000302	CcSEcCtD
Etidronic acid—Stevens-Johnson syndrome—Doxorubicin—hematologic cancer	0.000202	0.000302	CcSEcCtD
Etidronic acid—Vomiting—Ifosfamide—hematologic cancer	0.000202	0.000301	CcSEcCtD
Etidronic acid—Hypersensitivity—Cisplatin—hematologic cancer	0.000202	0.000301	CcSEcCtD
Etidronic acid—ATP6V1A—Disease—NCOR1—hematologic cancer	0.000202	0.00104	CbGpPWpGaD
Etidronic acid—Headache—Alitretinoin—hematologic cancer	0.000201	0.0003	CcSEcCtD
Etidronic acid—Angioedema—Prednisone—hematologic cancer	0.000201	0.0003	CcSEcCtD
Etidronic acid—Diarrhoea—Gemcitabine—hematologic cancer	0.000201	0.0003	CcSEcCtD
Etidronic acid—Nausea—Thalidomide—hematologic cancer	0.000201	0.000299	CcSEcCtD
Etidronic acid—Dyspepsia—Triamcinolone—hematologic cancer	0.0002	0.000299	CcSEcCtD
Etidronic acid—Rash—Ifosfamide—hematologic cancer	0.0002	0.000299	CcSEcCtD
Etidronic acid—Dermatitis—Ifosfamide—hematologic cancer	0.0002	0.000298	CcSEcCtD
Etidronic acid—Erythema multiforme—Methotrexate—hematologic cancer	0.0002	0.000298	CcSEcCtD
Etidronic acid—Neuropathy peripheral—Doxorubicin—hematologic cancer	0.0002	0.000298	CcSEcCtD
Etidronic acid—ATP6V1A—Signaling Pathways—PRKCZ—hematologic cancer	0.0002	0.00103	CbGpPWpGaD
Etidronic acid—ATP6V1A—Disease—FGF1—hematologic cancer	0.000199	0.00103	CbGpPWpGaD
Etidronic acid—Urticaria—Etoposide—hematologic cancer	0.000199	0.000297	CcSEcCtD
Etidronic acid—Abdominal pain—Etoposide—hematologic cancer	0.000198	0.000296	CcSEcCtD
Etidronic acid—Vomiting—Vincristine—hematologic cancer	0.000197	0.000294	CcSEcCtD
Etidronic acid—Urticaria—Prednisolone—hematologic cancer	0.000197	0.000293	CcSEcCtD
Etidronic acid—ATP6V1A—Disease—FOXO1—hematologic cancer	0.000197	0.00101	CbGpPWpGaD
Etidronic acid—ATP6V1A—Disease—PDGFRB—hematologic cancer	0.000196	0.00101	CbGpPWpGaD
Etidronic acid—Rash—Vincristine—hematologic cancer	0.000195	0.000291	CcSEcCtD
Etidronic acid—Dermatitis—Vincristine—hematologic cancer	0.000195	0.000291	CcSEcCtD
Etidronic acid—Headache—Vincristine—hematologic cancer	0.000194	0.000289	CcSEcCtD
Etidronic acid—ATP6V1A—Signaling Pathways—PARP1—hematologic cancer	0.000193	0.000995	CbGpPWpGaD
Etidronic acid—ATP6V1A—Disease—PDGFRA—hematologic cancer	0.000193	0.000995	CbGpPWpGaD
Etidronic acid—Nausea—Carmustine—hematologic cancer	0.000193	0.000287	CcSEcCtD
Etidronic acid—ATP6V1A—Disease—JAK1—hematologic cancer	0.000193	0.000992	CbGpPWpGaD
Etidronic acid—ATP6V1A—Disease—PRKCG—hematologic cancer	0.000193	0.000992	CbGpPWpGaD
Etidronic acid—Vomiting—Mitoxantrone—hematologic cancer	0.000192	0.000286	CcSEcCtD
Etidronic acid—Vomiting—Irinotecan—hematologic cancer	0.000192	0.000286	CcSEcCtD
Etidronic acid—Nausea—Alitretinoin—hematologic cancer	0.000191	0.000285	CcSEcCtD
Etidronic acid—Agranulocytosis—Doxorubicin—hematologic cancer	0.000191	0.000284	CcSEcCtD
Etidronic acid—Rash—Irinotecan—hematologic cancer	0.00019	0.000284	CcSEcCtD
Etidronic acid—Rash—Mitoxantrone—hematologic cancer	0.00019	0.000284	CcSEcCtD
Etidronic acid—Dermatitis—Irinotecan—hematologic cancer	0.00019	0.000283	CcSEcCtD
Etidronic acid—Dermatitis—Mitoxantrone—hematologic cancer	0.00019	0.000283	CcSEcCtD
Etidronic acid—ATP6V1A—Signaling Pathways—FBXW7—hematologic cancer	0.00019	0.000979	CbGpPWpGaD
Etidronic acid—Headache—Mitoxantrone—hematologic cancer	0.000189	0.000282	CcSEcCtD
Etidronic acid—Headache—Irinotecan—hematologic cancer	0.000189	0.000282	CcSEcCtD
Etidronic acid—Nausea—Ifosfamide—hematologic cancer	0.000189	0.000281	CcSEcCtD
Etidronic acid—Musculoskeletal discomfort—Betamethasone—hematologic cancer	0.000188	0.000281	CcSEcCtD
Etidronic acid—Musculoskeletal discomfort—Dexamethasone—hematologic cancer	0.000188	0.000281	CcSEcCtD
Etidronic acid—Arthralgia—Prednisone—hematologic cancer	0.000188	0.00028	CcSEcCtD
Etidronic acid—Feeling abnormal—Triamcinolone—hematologic cancer	0.000188	0.00028	CcSEcCtD
Etidronic acid—Diarrhoea—Cisplatin—hematologic cancer	0.000187	0.00028	CcSEcCtD
Etidronic acid—Erythema multiforme—Epirubicin—hematologic cancer	0.000187	0.000279	CcSEcCtD
Etidronic acid—Alopecia—Methotrexate—hematologic cancer	0.000187	0.000279	CcSEcCtD
Etidronic acid—Vomiting—Gemcitabine—hematologic cancer	0.000187	0.000279	CcSEcCtD
Etidronic acid—ATP6V1A—Signaling Pathways—CXCR4—hematologic cancer	0.000186	0.00096	CbGpPWpGaD
Etidronic acid—ATP6V1A—Signaling Pathways—HDAC2—hematologic cancer	0.000186	0.00096	CbGpPWpGaD
Etidronic acid—Paraesthesia—Dexamethasone—hematologic cancer	0.000186	0.000277	CcSEcCtD
Etidronic acid—Paraesthesia—Betamethasone—hematologic cancer	0.000186	0.000277	CcSEcCtD
Etidronic acid—Discomfort—Prednisone—hematologic cancer	0.000185	0.000276	CcSEcCtD
Etidronic acid—Rash—Gemcitabine—hematologic cancer	0.000185	0.000276	CcSEcCtD
Etidronic acid—Dermatitis—Gemcitabine—hematologic cancer	0.000185	0.000276	CcSEcCtD
Etidronic acid—Hypersensitivity—Etoposide—hematologic cancer	0.000185	0.000276	CcSEcCtD
Etidronic acid—Erythema—Methotrexate—hematologic cancer	0.000184	0.000275	CcSEcCtD
Etidronic acid—Headache—Gemcitabine—hematologic cancer	0.000184	0.000275	CcSEcCtD
Etidronic acid—Nausea—Vincristine—hematologic cancer	0.000184	0.000274	CcSEcCtD
Etidronic acid—Hypersensitivity—Prednisolone—hematologic cancer	0.000182	0.000272	CcSEcCtD
Etidronic acid—Dyspepsia—Dexamethasone—hematologic cancer	0.000182	0.000271	CcSEcCtD
Etidronic acid—Dyspepsia—Betamethasone—hematologic cancer	0.000182	0.000271	CcSEcCtD
Etidronic acid—ATP6V1A—Signaling Pathways—CBL—hematologic cancer	0.000182	0.000936	CbGpPWpGaD
Etidronic acid—Urticaria—Triamcinolone—hematologic cancer	0.000181	0.00027	CcSEcCtD
Etidronic acid—ATP6V1A—Signaling Pathways—IL3—hematologic cancer	0.00018	0.000926	CbGpPWpGaD
Etidronic acid—Nausea—Mitoxantrone—hematologic cancer	0.000179	0.000267	CcSEcCtD
Etidronic acid—Nausea—Irinotecan—hematologic cancer	0.000179	0.000267	CcSEcCtD
Etidronic acid—Infection—Prednisone—hematologic cancer	0.000179	0.000266	CcSEcCtD
Etidronic acid—ATP6V1A—Disease—MTHFR—hematologic cancer	0.000178	0.000919	CbGpPWpGaD
Etidronic acid—ATP6V1A—Disease—HLA-A—hematologic cancer	0.000178	0.000916	CbGpPWpGaD
Etidronic acid—ATP6V1A—Disease—TERT—hematologic cancer	0.000178	0.000916	CbGpPWpGaD
Etidronic acid—Pruritus—Etoposide—hematologic cancer	0.000178	0.000265	CcSEcCtD
Etidronic acid—ATP6V1A—Signaling Pathways—PTPN1—hematologic cancer	0.000177	0.00091	CbGpPWpGaD
Etidronic acid—Alopecia—Epirubicin—hematologic cancer	0.000175	0.000261	CcSEcCtD
Etidronic acid—Nausea—Gemcitabine—hematologic cancer	0.000175	0.00026	CcSEcCtD
Etidronic acid—Vomiting—Cisplatin—hematologic cancer	0.000174	0.00026	CcSEcCtD
Etidronic acid—ATP6V1A—Signaling Pathways—RASGRP1—hematologic cancer	0.000174	0.000896	CbGpPWpGaD
Etidronic acid—ATP6V1A—Disease—PDGFB—hematologic cancer	0.000174	0.000894	CbGpPWpGaD
Etidronic acid—Erythema multiforme—Doxorubicin—hematologic cancer	0.000173	0.000258	CcSEcCtD
Etidronic acid—ATP6V1A—Signaling Pathways—SYK—hematologic cancer	0.000173	0.000893	CbGpPWpGaD
Etidronic acid—ATP6V1A—Signaling Pathways—HSP90AA1—hematologic cancer	0.000173	0.000893	CbGpPWpGaD
Etidronic acid—Rash—Cisplatin—hematologic cancer	0.000173	0.000258	CcSEcCtD
Etidronic acid—Dermatitis—Cisplatin—hematologic cancer	0.000173	0.000257	CcSEcCtD
Etidronic acid—Erythema—Epirubicin—hematologic cancer	0.000172	0.000257	CcSEcCtD
Etidronic acid—Diarrhoea—Etoposide—hematologic cancer	0.000172	0.000256	CcSEcCtD
Etidronic acid—Anaemia—Methotrexate—hematologic cancer	0.00017	0.000254	CcSEcCtD
Etidronic acid—Feeling abnormal—Dexamethasone—hematologic cancer	0.00017	0.000254	CcSEcCtD
Etidronic acid—Feeling abnormal—Betamethasone—hematologic cancer	0.00017	0.000254	CcSEcCtD
Etidronic acid—Flatulence—Epirubicin—hematologic cancer	0.00017	0.000253	CcSEcCtD
Etidronic acid—ATP6V1A—Disease—TSC2—hematologic cancer	0.00017	0.000874	CbGpPWpGaD
Etidronic acid—Gastrointestinal pain—Betamethasone—hematologic cancer	0.000169	0.000252	CcSEcCtD
Etidronic acid—Gastrointestinal pain—Dexamethasone—hematologic cancer	0.000169	0.000252	CcSEcCtD
Etidronic acid—Hypersensitivity—Triamcinolone—hematologic cancer	0.000168	0.00025	CcSEcCtD
Etidronic acid—ATP6V1A—Signaling Pathways—STAT1—hematologic cancer	0.000167	0.000861	CbGpPWpGaD
Etidronic acid—Muscle spasms—Epirubicin—hematologic cancer	0.000166	0.000247	CcSEcCtD
Etidronic acid—Leukopenia—Methotrexate—hematologic cancer	0.000165	0.000246	CcSEcCtD
Etidronic acid—Urticaria—Dexamethasone—hematologic cancer	0.000164	0.000245	CcSEcCtD
Etidronic acid—Urticaria—Betamethasone—hematologic cancer	0.000164	0.000245	CcSEcCtD
Etidronic acid—Musculoskeletal discomfort—Prednisone—hematologic cancer	0.000164	0.000244	CcSEcCtD
Etidronic acid—Abdominal pain—Dexamethasone—hematologic cancer	0.000163	0.000243	CcSEcCtD
Etidronic acid—Abdominal pain—Betamethasone—hematologic cancer	0.000163	0.000243	CcSEcCtD
Etidronic acid—ATP6V1A—Disease—FGFR3—hematologic cancer	0.000163	0.000841	CbGpPWpGaD
Etidronic acid—Nausea—Cisplatin—hematologic cancer	0.000163	0.000243	CcSEcCtD
Etidronic acid—Alopecia—Doxorubicin—hematologic cancer	0.000162	0.000241	CcSEcCtD
Etidronic acid—Paraesthesia—Prednisone—hematologic cancer	0.000162	0.000241	CcSEcCtD
Etidronic acid—Pruritus—Triamcinolone—hematologic cancer	0.000161	0.00024	CcSEcCtD
Etidronic acid—Vomiting—Etoposide—hematologic cancer	0.00016	0.000238	CcSEcCtD
Etidronic acid—Erythema—Doxorubicin—hematologic cancer	0.00016	0.000238	CcSEcCtD
Etidronic acid—Anaemia—Epirubicin—hematologic cancer	0.000159	0.000238	CcSEcCtD
Etidronic acid—Dyspepsia—Prednisone—hematologic cancer	0.000158	0.000236	CcSEcCtD
Etidronic acid—Rash—Etoposide—hematologic cancer	0.000158	0.000236	CcSEcCtD
Etidronic acid—Dermatitis—Etoposide—hematologic cancer	0.000158	0.000236	CcSEcCtD
Etidronic acid—Headache—Etoposide—hematologic cancer	0.000157	0.000234	CcSEcCtD
Etidronic acid—Flatulence—Doxorubicin—hematologic cancer	0.000157	0.000234	CcSEcCtD
Etidronic acid—Arthralgia—Methotrexate—hematologic cancer	0.000157	0.000234	CcSEcCtD
Etidronic acid—ATP6V1A—Signaling Pathways—GRB2—hematologic cancer	0.000156	0.000805	CbGpPWpGaD
Etidronic acid—Rash—Prednisolone—hematologic cancer	0.000156	0.000233	CcSEcCtD
Etidronic acid—Dermatitis—Prednisolone—hematologic cancer	0.000156	0.000233	CcSEcCtD
Etidronic acid—ATP6V1A—Signaling Pathways—PDGFA—hematologic cancer	0.000156	0.000804	CbGpPWpGaD
Etidronic acid—Headache—Prednisolone—hematologic cancer	0.000155	0.000231	CcSEcCtD
Etidronic acid—Discomfort—Methotrexate—hematologic cancer	0.000155	0.000231	CcSEcCtD
Etidronic acid—ATP6V1A—Disease—BAD—hematologic cancer	0.000155	0.000797	CbGpPWpGaD
Etidronic acid—Leukopenia—Epirubicin—hematologic cancer	0.000154	0.00023	CcSEcCtD
Etidronic acid—Constipation—Prednisone—hematologic cancer	0.000154	0.000229	CcSEcCtD
Etidronic acid—ATP6V1A—Signaling Pathways—KITLG—hematologic cancer	0.000154	0.000792	CbGpPWpGaD
Etidronic acid—Muscle spasms—Doxorubicin—hematologic cancer	0.000153	0.000229	CcSEcCtD
Etidronic acid—ATP6V1A—Disease—NOTCH1—hematologic cancer	0.000153	0.000789	CbGpPWpGaD
Etidronic acid—Confusional state—Methotrexate—hematologic cancer	0.000152	0.000226	CcSEcCtD
Etidronic acid—ATP6V1A—Signaling Pathways—STAT5A—hematologic cancer	0.00015	0.000774	CbGpPWpGaD
Etidronic acid—ATP6V1A—Disease—CD80—hematologic cancer	0.00015	0.000773	CbGpPWpGaD
Etidronic acid—ATP6V1A—Disease—KIT—hematologic cancer	0.00015	0.000772	CbGpPWpGaD
Etidronic acid—Infection—Methotrexate—hematologic cancer	0.000149	0.000223	CcSEcCtD
Etidronic acid—Nausea—Etoposide—hematologic cancer	0.000149	0.000222	CcSEcCtD
Etidronic acid—ATP6V1A—Signaling Pathways—CDKN2B—hematologic cancer	0.000149	0.000767	CbGpPWpGaD
Etidronic acid—Feeling abnormal—Prednisone—hematologic cancer	0.000148	0.000221	CcSEcCtD
Etidronic acid—Anaemia—Doxorubicin—hematologic cancer	0.000147	0.00022	CcSEcCtD
Etidronic acid—ATP6V1A—Disease—PTPN11—hematologic cancer	0.000147	0.000758	CbGpPWpGaD
Etidronic acid—Gastrointestinal pain—Prednisone—hematologic cancer	0.000147	0.000219	CcSEcCtD
Etidronic acid—Nausea—Prednisolone—hematologic cancer	0.000147	0.000219	CcSEcCtD
Etidronic acid—Arthralgia—Epirubicin—hematologic cancer	0.000147	0.000219	CcSEcCtD
Etidronic acid—Pruritus—Betamethasone—hematologic cancer	0.000146	0.000218	CcSEcCtD
Etidronic acid—Pruritus—Dexamethasone—hematologic cancer	0.000146	0.000218	CcSEcCtD
Etidronic acid—Discomfort—Epirubicin—hematologic cancer	0.000145	0.000216	CcSEcCtD
Etidronic acid—Vomiting—Triamcinolone—hematologic cancer	0.000145	0.000216	CcSEcCtD
Etidronic acid—ATP6V1A—Signaling Pathways—CD86—hematologic cancer	0.000144	0.000742	CbGpPWpGaD
Etidronic acid—Rash—Triamcinolone—hematologic cancer	0.000144	0.000214	CcSEcCtD
Etidronic acid—Dermatitis—Triamcinolone—hematologic cancer	0.000143	0.000214	CcSEcCtD
Etidronic acid—Urticaria—Prednisone—hematologic cancer	0.000143	0.000213	CcSEcCtD
Etidronic acid—Leukopenia—Doxorubicin—hematologic cancer	0.000143	0.000213	CcSEcCtD
Etidronic acid—Headache—Triamcinolone—hematologic cancer	0.000143	0.000213	CcSEcCtD
Etidronic acid—ATP6V1A—Disease—CREB1—hematologic cancer	0.000143	0.000735	CbGpPWpGaD
Etidronic acid—Abdominal pain—Prednisone—hematologic cancer	0.000142	0.000212	CcSEcCtD
Etidronic acid—ATP6V1A—Signaling Pathways—HES1—hematologic cancer	0.000142	0.000732	CbGpPWpGaD
Etidronic acid—Confusional state—Epirubicin—hematologic cancer	0.000142	0.000212	CcSEcCtD
Etidronic acid—Diarrhoea—Dexamethasone—hematologic cancer	0.000141	0.000211	CcSEcCtD
Etidronic acid—Diarrhoea—Betamethasone—hematologic cancer	0.000141	0.000211	CcSEcCtD
Etidronic acid—ATP6V1A—Signaling Pathways—NCOR1—hematologic cancer	0.000141	0.000728	CbGpPWpGaD
Etidronic acid—ATP6V1A—Disease—BRAF—hematologic cancer	0.000141	0.000725	CbGpPWpGaD
Etidronic acid—Infection—Epirubicin—hematologic cancer	0.00014	0.000208	CcSEcCtD
Etidronic acid—ATP6V1A—Signaling Pathways—FGF1—hematologic cancer	0.00014	0.00072	CbGpPWpGaD
Etidronic acid—ATP6V1A—Signaling Pathways—CSF2—hematologic cancer	0.00014	0.00072	CbGpPWpGaD
Etidronic acid—ATP6V1A—Disease—IL6R—hematologic cancer	0.000139	0.000717	CbGpPWpGaD
Etidronic acid—ATP6V1A—Disease—CREBBP—hematologic cancer	0.000139	0.000716	CbGpPWpGaD
Etidronic acid—ATP6V1A—Signaling Pathways—FOXO1—hematologic cancer	0.000138	0.000709	CbGpPWpGaD
Etidronic acid—ATP6V1A—Signaling Pathways—PDGFRB—hematologic cancer	0.000137	0.000708	CbGpPWpGaD
Etidronic acid—Musculoskeletal discomfort—Methotrexate—hematologic cancer	0.000137	0.000204	CcSEcCtD
Etidronic acid—Arthralgia—Doxorubicin—hematologic cancer	0.000136	0.000202	CcSEcCtD
Etidronic acid—ATP6V1A—Signaling Pathways—PDGFRA—hematologic cancer	0.000135	0.000697	CbGpPWpGaD
Etidronic acid—Nausea—Triamcinolone—hematologic cancer	0.000135	0.000202	CcSEcCtD
Etidronic acid—Paraesthesia—Methotrexate—hematologic cancer	0.000135	0.000201	CcSEcCtD
Etidronic acid—ATP6V1A—Signaling Pathways—JAK1—hematologic cancer	0.000135	0.000695	CbGpPWpGaD
Etidronic acid—ATP6V1A—Signaling Pathways—PRKCG—hematologic cancer	0.000135	0.000695	CbGpPWpGaD
Etidronic acid—Discomfort—Doxorubicin—hematologic cancer	0.000134	0.0002	CcSEcCtD
Etidronic acid—Hypersensitivity—Prednisone—hematologic cancer	0.000133	0.000198	CcSEcCtD
Etidronic acid—ATP6V1A—Disease—MAP2K1—hematologic cancer	0.000133	0.000683	CbGpPWpGaD
Etidronic acid—Dyspepsia—Methotrexate—hematologic cancer	0.000132	0.000197	CcSEcCtD
Etidronic acid—ATP6V1A—Disease—PIK3CD—hematologic cancer	0.000132	0.000678	CbGpPWpGaD
Etidronic acid—Vomiting—Dexamethasone—hematologic cancer	0.000131	0.000196	CcSEcCtD
Etidronic acid—Vomiting—Betamethasone—hematologic cancer	0.000131	0.000196	CcSEcCtD
Etidronic acid—Confusional state—Doxorubicin—hematologic cancer	0.000131	0.000196	CcSEcCtD
Etidronic acid—Rash—Betamethasone—hematologic cancer	0.00013	0.000194	CcSEcCtD
Etidronic acid—Rash—Dexamethasone—hematologic cancer	0.00013	0.000194	CcSEcCtD
Etidronic acid—Dermatitis—Betamethasone—hematologic cancer	0.00013	0.000194	CcSEcCtD
Etidronic acid—Dermatitis—Dexamethasone—hematologic cancer	0.00013	0.000194	CcSEcCtD
Etidronic acid—Headache—Dexamethasone—hematologic cancer	0.000129	0.000193	CcSEcCtD
Etidronic acid—Headache—Betamethasone—hematologic cancer	0.000129	0.000193	CcSEcCtD
Etidronic acid—Infection—Doxorubicin—hematologic cancer	0.000129	0.000193	CcSEcCtD
Etidronic acid—Musculoskeletal discomfort—Epirubicin—hematologic cancer	0.000128	0.000191	CcSEcCtD
Etidronic acid—Pruritus—Prednisone—hematologic cancer	0.000127	0.00019	CcSEcCtD
Etidronic acid—Paraesthesia—Epirubicin—hematologic cancer	0.000126	0.000188	CcSEcCtD
Etidronic acid—ATP6V1A—Disease—FGF2—hematologic cancer	0.000126	0.00065	CbGpPWpGaD
Etidronic acid—ATP6V1A—Signaling Pathways—IL2RA—hematologic cancer	0.000126	0.000649	CbGpPWpGaD
Etidronic acid—ATP6V1A—Signaling Pathways—TERT—hematologic cancer	0.000124	0.000641	CbGpPWpGaD
Etidronic acid—ATP6V1A—Disease—PIK3R1—hematologic cancer	0.000124	0.000641	CbGpPWpGaD
Etidronic acid—Feeling abnormal—Methotrexate—hematologic cancer	0.000124	0.000185	CcSEcCtD
Etidronic acid—Dyspepsia—Epirubicin—hematologic cancer	0.000124	0.000185	CcSEcCtD
Etidronic acid—Diarrhoea—Prednisone—hematologic cancer	0.000123	0.000184	CcSEcCtD
Etidronic acid—Gastrointestinal pain—Methotrexate—hematologic cancer	0.000123	0.000183	CcSEcCtD
Etidronic acid—Nausea—Dexamethasone—hematologic cancer	0.000123	0.000183	CcSEcCtD
Etidronic acid—Nausea—Betamethasone—hematologic cancer	0.000123	0.000183	CcSEcCtD
Etidronic acid—ATP6V1A—Signaling Pathways—PDGFB—hematologic cancer	0.000122	0.000626	CbGpPWpGaD
Etidronic acid—ATP6V1A—Disease—JAK2—hematologic cancer	0.000121	0.000623	CbGpPWpGaD
Etidronic acid—Constipation—Epirubicin—hematologic cancer	0.00012	0.000179	CcSEcCtD
Etidronic acid—Urticaria—Methotrexate—hematologic cancer	0.000119	0.000178	CcSEcCtD
Etidronic acid—Abdominal pain—Methotrexate—hematologic cancer	0.000119	0.000177	CcSEcCtD
Etidronic acid—ATP6V1A—Signaling Pathways—TSC2—hematologic cancer	0.000119	0.000612	CbGpPWpGaD
Etidronic acid—Musculoskeletal discomfort—Doxorubicin—hematologic cancer	0.000119	0.000177	CcSEcCtD
Etidronic acid—ATP6V1A—Disease—MDM2—hematologic cancer	0.000118	0.000608	CbGpPWpGaD
Etidronic acid—Paraesthesia—Doxorubicin—hematologic cancer	0.000117	0.000174	CcSEcCtD
Etidronic acid—Feeling abnormal—Epirubicin—hematologic cancer	0.000116	0.000173	CcSEcCtD
Etidronic acid—Gastrointestinal pain—Epirubicin—hematologic cancer	0.000115	0.000172	CcSEcCtD
Etidronic acid—ATP6V1A—Disease—MTOR—hematologic cancer	0.000115	0.000591	CbGpPWpGaD
Etidronic acid—ATP6V1A—Disease—PIK3CB—hematologic cancer	0.000115	0.000591	CbGpPWpGaD
Etidronic acid—Dyspepsia—Doxorubicin—hematologic cancer	0.000115	0.000171	CcSEcCtD
Etidronic acid—ATP6V1A—Disease—CD4—hematologic cancer	0.000115	0.00059	CbGpPWpGaD
Etidronic acid—Vomiting—Prednisone—hematologic cancer	0.000114	0.000171	CcSEcCtD
Etidronic acid—ATP6V1A—Signaling Pathways—FGFR3—hematologic cancer	0.000114	0.000589	CbGpPWpGaD
Etidronic acid—Rash—Prednisone—hematologic cancer	0.000113	0.000169	CcSEcCtD
Etidronic acid—Dermatitis—Prednisone—hematologic cancer	0.000113	0.000169	CcSEcCtD
Etidronic acid—ATP6V1A—Signaling Pathways—MAPK14—hematologic cancer	0.000113	0.000583	CbGpPWpGaD
Etidronic acid—Headache—Prednisone—hematologic cancer	0.000113	0.000168	CcSEcCtD
Etidronic acid—Urticaria—Epirubicin—hematologic cancer	0.000112	0.000167	CcSEcCtD
Etidronic acid—Constipation—Doxorubicin—hematologic cancer	0.000111	0.000166	CcSEcCtD
Etidronic acid—Abdominal pain—Epirubicin—hematologic cancer	0.000111	0.000166	CcSEcCtD
Etidronic acid—ATP6V1A—Signaling Pathways—ESR1—hematologic cancer	0.000111	0.000572	CbGpPWpGaD
Etidronic acid—Hypersensitivity—Methotrexate—hematologic cancer	0.000111	0.000165	CcSEcCtD
Etidronic acid—ATP6V1A—Signaling Pathways—FN1—hematologic cancer	0.00011	0.000565	CbGpPWpGaD
Etidronic acid—ATP6V1A—Signaling Pathways—BAD—hematologic cancer	0.000108	0.000558	CbGpPWpGaD
Etidronic acid—ATP6V1A—Signaling Pathways—NFKBIA—hematologic cancer	0.000108	0.000558	CbGpPWpGaD
Etidronic acid—ATP6V1A—Disease—CDKN1B—hematologic cancer	0.000108	0.000555	CbGpPWpGaD
Etidronic acid—Feeling abnormal—Doxorubicin—hematologic cancer	0.000107	0.00016	CcSEcCtD
Etidronic acid—ATP6V1A—Signaling Pathways—NOTCH1—hematologic cancer	0.000107	0.000553	CbGpPWpGaD
Etidronic acid—Nausea—Prednisone—hematologic cancer	0.000107	0.000159	CcSEcCtD
Etidronic acid—Gastrointestinal pain—Doxorubicin—hematologic cancer	0.000106	0.000159	CcSEcCtD
Etidronic acid—Pruritus—Methotrexate—hematologic cancer	0.000106	0.000159	CcSEcCtD
Etidronic acid—ATP6V1A—Signaling Pathways—CD80—hematologic cancer	0.000105	0.000541	CbGpPWpGaD
Etidronic acid—ATP6V1A—Signaling Pathways—KIT—hematologic cancer	0.000105	0.00054	CbGpPWpGaD
Etidronic acid—ATP6V1A—Signaling Pathways—PIK3CG—hematologic cancer	0.000105	0.00054	CbGpPWpGaD
Etidronic acid—Hypersensitivity—Epirubicin—hematologic cancer	0.000104	0.000155	CcSEcCtD
Etidronic acid—Urticaria—Doxorubicin—hematologic cancer	0.000103	0.000154	CcSEcCtD
Etidronic acid—ATP6V1A—Signaling Pathways—PTPN11—hematologic cancer	0.000103	0.000531	CbGpPWpGaD
Etidronic acid—Abdominal pain—Doxorubicin—hematologic cancer	0.000103	0.000153	CcSEcCtD
Etidronic acid—Diarrhoea—Methotrexate—hematologic cancer	0.000103	0.000153	CcSEcCtD
Etidronic acid—ATP6V1A—Signaling Pathways—CREB1—hematologic cancer	9.98e-05	0.000514	CbGpPWpGaD
Etidronic acid—Pruritus—Epirubicin—hematologic cancer	9.96e-05	0.000148	CcSEcCtD
Etidronic acid—ATP6V1A—Disease—CDKN1A—hematologic cancer	9.94e-05	0.000512	CbGpPWpGaD
Etidronic acid—ATP6V1A—Disease—PTEN—hematologic cancer	9.92e-05	0.000511	CbGpPWpGaD
Etidronic acid—ATP6V1A—Signaling Pathways—BRAF—hematologic cancer	9.86e-05	0.000508	CbGpPWpGaD
Etidronic acid—ATP6V1A—Signaling Pathways—CCL2—hematologic cancer	9.77e-05	0.000503	CbGpPWpGaD
Etidronic acid—ATP6V1A—Signaling Pathways—IL6R—hematologic cancer	9.74e-05	0.000502	CbGpPWpGaD
Etidronic acid—ATP6V1A—Signaling Pathways—CREBBP—hematologic cancer	9.72e-05	0.000501	CbGpPWpGaD
Etidronic acid—Diarrhoea—Epirubicin—hematologic cancer	9.63e-05	0.000144	CcSEcCtD
Etidronic acid—Hypersensitivity—Doxorubicin—hematologic cancer	9.59e-05	0.000143	CcSEcCtD
Etidronic acid—Vomiting—Methotrexate—hematologic cancer	9.56e-05	0.000143	CcSEcCtD
Etidronic acid—Rash—Methotrexate—hematologic cancer	9.48e-05	0.000141	CcSEcCtD
Etidronic acid—Dermatitis—Methotrexate—hematologic cancer	9.47e-05	0.000141	CcSEcCtD
Etidronic acid—ATP6V1A—Disease—EP300—hematologic cancer	9.46e-05	0.000487	CbGpPWpGaD
Etidronic acid—Headache—Methotrexate—hematologic cancer	9.42e-05	0.00014	CcSEcCtD
Etidronic acid—ATP6V1A—Signaling Pathways—MAP2K1—hematologic cancer	9.28e-05	0.000478	CbGpPWpGaD
Etidronic acid—ATP6V1A—Signaling Pathways—PIK3CD—hematologic cancer	9.22e-05	0.000475	CbGpPWpGaD
Etidronic acid—Pruritus—Doxorubicin—hematologic cancer	9.21e-05	0.000137	CcSEcCtD
Etidronic acid—ATP6V1A—Disease—SRC—hematologic cancer	9.2e-05	0.000474	CbGpPWpGaD
Etidronic acid—Vomiting—Epirubicin—hematologic cancer	8.95e-05	0.000133	CcSEcCtD
Etidronic acid—Nausea—Methotrexate—hematologic cancer	8.93e-05	0.000133	CcSEcCtD
Etidronic acid—Diarrhoea—Doxorubicin—hematologic cancer	8.91e-05	0.000133	CcSEcCtD
Etidronic acid—Rash—Epirubicin—hematologic cancer	8.87e-05	0.000132	CcSEcCtD
Etidronic acid—ATP6V1A—Disease—STAT3—hematologic cancer	8.87e-05	0.000457	CbGpPWpGaD
Etidronic acid—Dermatitis—Epirubicin—hematologic cancer	8.86e-05	0.000132	CcSEcCtD
Etidronic acid—ATP6V1A—Disease—NRAS—hematologic cancer	8.85e-05	0.000456	CbGpPWpGaD
Etidronic acid—ATP6V1A—Signaling Pathways—FGF2—hematologic cancer	8.83e-05	0.000455	CbGpPWpGaD
Etidronic acid—Headache—Epirubicin—hematologic cancer	8.82e-05	0.000131	CcSEcCtD
Etidronic acid—ATP6V1A—Signaling Pathways—PIK3R1—hematologic cancer	8.71e-05	0.000449	CbGpPWpGaD
Etidronic acid—ATP6V1A—Disease—MAPK3—hematologic cancer	8.47e-05	0.000437	CbGpPWpGaD
Etidronic acid—ATP6V1A—Signaling Pathways—JAK2—hematologic cancer	8.46e-05	0.000436	CbGpPWpGaD
Etidronic acid—Nausea—Epirubicin—hematologic cancer	8.36e-05	0.000125	CcSEcCtD
Etidronic acid—Vomiting—Doxorubicin—hematologic cancer	8.28e-05	0.000123	CcSEcCtD
Etidronic acid—ATP6V1A—Signaling Pathways—MDM2—hematologic cancer	8.26e-05	0.000426	CbGpPWpGaD
Etidronic acid—ATP6V1A—Disease—MYC—hematologic cancer	8.24e-05	0.000425	CbGpPWpGaD
Etidronic acid—ATP6V1A—Disease—TGFB1—hematologic cancer	8.22e-05	0.000424	CbGpPWpGaD
Etidronic acid—Rash—Doxorubicin—hematologic cancer	8.21e-05	0.000122	CcSEcCtD
Etidronic acid—Dermatitis—Doxorubicin—hematologic cancer	8.2e-05	0.000122	CcSEcCtD
Etidronic acid—Headache—Doxorubicin—hematologic cancer	8.16e-05	0.000122	CcSEcCtD
Etidronic acid—ATP6V1A—Signaling Pathways—PIK3CB—hematologic cancer	8.04e-05	0.000414	CbGpPWpGaD
Etidronic acid—ATP6V1A—Signaling Pathways—MTOR—hematologic cancer	8.04e-05	0.000414	CbGpPWpGaD
Etidronic acid—Nausea—Doxorubicin—hematologic cancer	7.73e-05	0.000115	CcSEcCtD
Etidronic acid—ATP6V1A—Disease—KRAS—hematologic cancer	7.62e-05	0.000392	CbGpPWpGaD
Etidronic acid—ATP6V1A—Signaling Pathways—CDKN1B—hematologic cancer	7.54e-05	0.000389	CbGpPWpGaD
Etidronic acid—ATP6V1A—Signaling Pathways—CASP3—hematologic cancer	7.39e-05	0.000381	CbGpPWpGaD
Etidronic acid—ATP6V1A—Signaling Pathways—IL2—hematologic cancer	7.38e-05	0.00038	CbGpPWpGaD
Etidronic acid—ATP6V1A—Signaling Pathways—CCND1—hematologic cancer	7.2e-05	0.000371	CbGpPWpGaD
Etidronic acid—ATP6V1A—Signaling Pathways—JUN—hematologic cancer	7.18e-05	0.00037	CbGpPWpGaD
Etidronic acid—ATP6V1A—Disease—PIK3CA—hematologic cancer	7e-05	0.000361	CbGpPWpGaD
Etidronic acid—ATP6V1A—Signaling Pathways—CDKN1A—hematologic cancer	6.96e-05	0.000359	CbGpPWpGaD
Etidronic acid—ATP6V1A—Signaling Pathways—PTEN—hematologic cancer	6.94e-05	0.000358	CbGpPWpGaD
Etidronic acid—ATP6V1A—Signaling Pathways—MAPK8—hematologic cancer	6.79e-05	0.00035	CbGpPWpGaD
Etidronic acid—ATP6V1A—Signaling Pathways—EP300—hematologic cancer	6.62e-05	0.000341	CbGpPWpGaD
Etidronic acid—ATP6V1A—Disease—HRAS—hematologic cancer	6.47e-05	0.000334	CbGpPWpGaD
Etidronic acid—ATP6V1A—Signaling Pathways—SRC—hematologic cancer	6.44e-05	0.000332	CbGpPWpGaD
Etidronic acid—ATP6V1A—Signaling Pathways—VEGFA—hematologic cancer	6.27e-05	0.000323	CbGpPWpGaD
Etidronic acid—ATP6V1A—Signaling Pathways—STAT3—hematologic cancer	6.21e-05	0.00032	CbGpPWpGaD
Etidronic acid—ATP6V1A—Signaling Pathways—NRAS—hematologic cancer	6.2e-05	0.000319	CbGpPWpGaD
Etidronic acid—ATP6V1A—Disease—IL6—hematologic cancer	6.2e-05	0.000319	CbGpPWpGaD
Etidronic acid—ATP6V1A—Signaling Pathways—MAPK3—hematologic cancer	5.93e-05	0.000306	CbGpPWpGaD
Etidronic acid—ATP6V1A—Signaling Pathways—MYC—hematologic cancer	5.77e-05	0.000297	CbGpPWpGaD
Etidronic acid—ATP6V1A—Signaling Pathways—TGFB1—hematologic cancer	5.76e-05	0.000297	CbGpPWpGaD
Etidronic acid—ATP6V1A—Disease—AKT1—hematologic cancer	5.72e-05	0.000295	CbGpPWpGaD
Etidronic acid—ATP6V1A—Signaling Pathways—KRAS—hematologic cancer	5.33e-05	0.000275	CbGpPWpGaD
Etidronic acid—ATP6V1A—Signaling Pathways—PIK3CA—hematologic cancer	4.9e-05	0.000252	CbGpPWpGaD
Etidronic acid—ATP6V1A—Signaling Pathways—TP53—hematologic cancer	4.74e-05	0.000244	CbGpPWpGaD
Etidronic acid—ATP6V1A—Signaling Pathways—HRAS—hematologic cancer	4.53e-05	0.000234	CbGpPWpGaD
Etidronic acid—ATP6V1A—Signaling Pathways—IL6—hematologic cancer	4.34e-05	0.000224	CbGpPWpGaD
Etidronic acid—ATP6V1A—Signaling Pathways—AKT1—hematologic cancer	4e-05	0.000206	CbGpPWpGaD
